UNSPSC 51282805: Propenidazole

This classification denotes an antiprotozoal agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F0O89MB7QE. European Medicines Agency schedules Propenidazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10101MIG. Propenidazole generally arises in the molecular formula C11H13N3O5.

UNSPSC 51282805 Propenidazole is a Commodity code that does not match the work actually being solicited under it in recent state and local procurement activity. The code's nominal scope — a specific chemical compound used in pharmaceutical manufacturing — bears no relation to the naloxone distribution, pharmacy benefit program design, emergency medical supplies, and generic pharmaceutical procurement that dominate the recent opportunities tagged to this code. State and local governments are not currently buying propenidazole itself; instead, the code appears to capture a broader and poorly aligned set of health-related product and service procurements that do not fit the code's definition.

The recent opportunities show activity from a county health department (Seminole County, Florida issuing an IFB for naloxone and drug deactivation systems), a state HHS commission (Texas issuing an RFI on direct-to-manufacturer prescription programs), a municipal fire department (City of Tampa issuing an IFB for medical and first aid supplies through a cooperative purchasing vehicle with a $700,000 estimated value and an SLBE set-aside), and a multistate cooperative purchasing alliance (MMCAP, administered by Minnesota with participation from Oregon, issuing an RFP for generic pharmaceuticals and OTC products with a response deadline of March 26, 2026). Geographic activity spans Florida, Texas, Minnesota, and Oregon. The code shows little relevant recent activity and suggests a tagging or classification misalignment rather than active procurement demand for the commodity itself.